Literature DB >> 15944922

Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.

N Garcia1, M M Santafé, I Salon, M A Lanuza, J Tomàs.   

Abstract

Using intracellular recording and immunohistochemistry, we studied the presynaptic muscarinic autoreceptor subtypes controlling ACh release in the neuromuscular junctions of the newborn (3-6 days postnatal) and adult (30-40 days) rat. In the Levator auris longus muscles of both newborn and adult rats, acetylcholine release was modified by the M1-receptor selective antagonists pirenzepine (10 microM) and MT-7 (100 nM) and by the M2-receptor selective antagonists methoctramine (1 microM) and AF-DX 116 (10 microM). The M4-receptor selective antagonists tropicamide (1 microM) and MT-3 (100 nM) can also modify the neurotransmitter release in certain synapses of the newborn muscles. The neurotransmitter release was not altered by the M3-receptor selective antagonist 4-DAMP (1 microM) in the adult or newborn rats. However, we directly demonstrate by immunocytochemistry the presence of these receptors in the motor endplates and conclude that M1-, M2-, M3- and M4-type muscarinic receptors are present in all the neuromuscular junctions of the rat muscle both in newborn and adult animals. These receptors may be located in the perisynaptic glial cell as well as at the nerve terminals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944922     DOI: 10.14670/HH-20.733

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  13 in total

1.  Muscarinic acetylcholine receptor subtype expression in avian vestibular hair cells, nerve terminals and ganglion cells.

Authors:  G Q Li; G A Kevetter; R B Leonard; D J Prusak; T G Wood; M J Correia
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

2.  Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.

Authors:  Haipeng Zhu; Bula J Bhattacharyya; Hong Lin; Christopher M Gomez
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

3.  Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.

Authors:  Megan C Wright; Srilatha Potluri; Xueyong Wang; Eva Dentcheva; Dinesh Gautam; Alan Tessler; Jürgen Wess; Mark M Rich; Young-Jin Son
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

4.  The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.

Authors:  Adrienne J Betz; Peter J McLaughlin; Melissa Burgos; Suzanne M Weber; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2007-06-27       Impact factor: 4.530

5.  Acetylcholine negatively regulates development of the neuromuscular junction through distinct cellular mechanisms.

Authors:  Mahru C An; Weichun Lin; Jiefei Yang; Bertha Dominguez; Daniel Padgett; Yoshie Sugiura; Prafulla Aryal; Thomas W Gould; Ronald W Oppenheim; Mark E Hester; Brian K Kaspar; Chien-Ping Ko; Kuo-Fen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

6.  The novel protein kinase C epsilon isoform modulates acetylcholine release in the rat neuromuscular junction.

Authors:  Teresa Obis; Erica Hurtado; Laura Nadal; Marta Tomàs; Mercedes Priego; Anna Simon; Neus Garcia; Manel M Santafe; Maria A Lanuza; Josep Tomàs
Journal:  Mol Brain       Date:  2015-12-01       Impact factor: 4.041

Review 7.  Presynaptic Membrane Receptors Modulate ACh Release, Axonal Competition and Synapse Elimination during Neuromuscular Junction Development.

Authors:  Josep Tomàs; Neus Garcia; Maria A Lanuza; Manel M Santafé; Marta Tomàs; Laura Nadal; Erica Hurtado; Anna Simó; Víctor Cilleros
Journal:  Front Mol Neurosci       Date:  2017-05-16       Impact factor: 5.639

Review 8.  Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes.

Authors:  Konstantin A Petrov; Evgeny E Nikolsky; Patrick Masson
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

9.  Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction.

Authors:  Laura Nadal; Neus Garcia; Erica Hurtado; Anna Simó; Marta Tomàs; Maria A Lanuza; Manel Santafé; Josep Tomàs
Journal:  Mol Brain       Date:  2016-06-23       Impact factor: 4.041

10.  Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways.

Authors:  Josep Tomàs; Neus Garcia; Maria A Lanuza; Manel M Santafé; Marta Tomàs; Laura Nadal; Erica Hurtado; Anna Simó-Ollé; Víctor Cilleros-Mañé; Laia Just-Borràs
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.